Free Trial

Nu Skin Enterprises (NUS) Competitors

Nu Skin Enterprises logo
$6.54 -0.40 (-5.70%)
Closing price 01/31/2025 03:59 PM Eastern
Extended Trading
$6.55 +0.01 (+0.23%)
As of 01/31/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NUS vs. USNA, HLF, NATR, MED, VERU, EL, IPAR, PBH, COSM, and HWH

Should you be buying Nu Skin Enterprises stock or one of its competitors? The main competitors of Nu Skin Enterprises include USANA Health Sciences (USNA), Herbalife (HLF), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Cosmos Health (COSM), and HWH International (HWH).

Nu Skin Enterprises vs.

USANA Health Sciences (NYSE:USNA) and Nu Skin Enterprises (NYSE:NUS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, community ranking, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

In the previous week, USANA Health Sciences had 2 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 3 mentions for USANA Health Sciences and 1 mentions for Nu Skin Enterprises. USANA Health Sciences' average media sentiment score of 0.84 beat Nu Skin Enterprises' score of -1.00 indicating that USANA Health Sciences is being referred to more favorably in the media.

Company Overall Sentiment
USANA Health Sciences Positive
Nu Skin Enterprises Negative

USANA Health Sciences currently has a consensus price target of $38.00, suggesting a potential upside of 16.60%. Nu Skin Enterprises has a consensus price target of $6.88, suggesting a potential upside of 5.20%. Given USANA Health Sciences' higher possible upside, equities analysts clearly believe USANA Health Sciences is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Nu Skin Enterprises
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

USANA Health Sciences has higher earnings, but lower revenue than Nu Skin Enterprises. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USANA Health Sciences$921.01M0.67$63.79M$2.8311.52
Nu Skin Enterprises$1.97B0.16$8.60M-$2.07-3.16

USANA Health Sciences has a net margin of 6.30% compared to Nu Skin Enterprises' net margin of -5.81%. USANA Health Sciences' return on equity of 10.64% beat Nu Skin Enterprises' return on equity.

Company Net Margins Return on Equity Return on Assets
USANA Health Sciences6.30% 10.64% 8.48%
Nu Skin Enterprises -5.81%5.47%2.46%

USANA Health Sciences has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500.

Nu Skin Enterprises received 114 more outperform votes than USANA Health Sciences when rated by MarketBeat users. Likewise, 63.92% of users gave Nu Skin Enterprises an outperform vote while only 60.49% of users gave USANA Health Sciences an outperform vote.

CompanyUnderperformOutperform
USANA Health SciencesOutperform Votes
398
60.49%
Underperform Votes
260
39.51%
Nu Skin EnterprisesOutperform Votes
512
63.92%
Underperform Votes
289
36.08%

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are owned by institutional investors. 0.3% of USANA Health Sciences shares are owned by company insiders. Comparatively, 1.7% of Nu Skin Enterprises shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

USANA Health Sciences beats Nu Skin Enterprises on 9 of the 15 factors compared between the two stocks.

Get Nu Skin Enterprises News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NUS vs. The Competition

MetricNu Skin EnterprisesDrugs, proprietaries, & sundries IndustryStaples SectorNYSE Exchange
Market Cap$343.01M$20.77B$16.15B$20.14B
Dividend Yield3.48%1.47%2.82%3.65%
P/E RatioN/A8.7717.1835.43
Price / Sales0.169.733.5518.31
Price / Cash2.1012.2417.4520.47
Price / Book0.3915.696.205.90
Net Income$8.60M$776.36M$608.39M$1.02B
7 Day Performance-5.23%-0.05%0.17%-0.56%
1 Month Performance-5.15%-6.61%2.13%4.18%
1 Year Performance-65.39%-15.48%7.71%16.86%

Nu Skin Enterprises Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NUS
Nu Skin Enterprises
2.8109 of 5 stars
$6.54
-5.7%
$6.88
+5.2%
-64.8%$343.01M$1.97B0.003,700Short Interest ↑
Negative News
USNA
USANA Health Sciences
4.4444 of 5 stars
$34.62
+0.8%
$38.00
+9.8%
-30.3%$659.93M$921.01M12.231,800
HLF
Herbalife
4.6785 of 5 stars
$6.54
+1.3%
$9.90
+51.5%
-54.8%$658.66M$5.06B7.699,200Short Interest ↑
NATR
Nature's Sunshine Products
3.3122 of 5 stars
$15.30
+6.0%
$19.00
+24.2%
-20.1%$282.82M$445.32M17.39850Positive News
MED
Medifast
2.0083 of 5 stars
$16.12
+2.3%
$17.00
+5.5%
-71.3%$176.32M$1.07B24.42870Positive News
VERU
Veru
2.0079 of 5 stars
$0.67
-45.0%
$4.00
+501.5%
+13.9%$96.46M$16.89M-2.35230High Trading Volume
EL
Estée Lauder Companies
4.8033 of 5 stars
$83.89
+1.7%
$93.68
+11.7%
-36.7%$30.11B$15.61B149.7962,000Upcoming Earnings
Analyst Forecast
Short Interest ↑
IPAR
Inter Parfums
4.0617 of 5 stars
$144.07
+2.2%
$159.40
+10.6%
+1.3%$4.61B$1.32B30.86530Analyst Revision
PBH
Prestige Consumer Healthcare
4.2307 of 5 stars
$79.26
+3.4%
$85.25
+7.6%
+24.7%$3.92B$1.13B19.30540
COSM
Cosmos Health
1.5183 of 5 stars
$0.75
-4.3%
N/A-33.8%$17.45M$53.38M-0.31100
HWH
HWH International
N/A$0.46
+59.2%
N/A-66.1%$14.41MN/A0.00N/AShort Interest ↓
High Trading Volume

Related Companies and Tools


This page (NYSE:NUS) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners